Similar ILC populations were enriched in the colonic mucosa of patients with inflammatory bowel disease (IBD) (Geremia et al., 2011), implicating IL-23-responsive, RORγt expressing ILCs in the pathogenesis of inflammatory gut disease in mice and humans. Here, IL23A is linked to inflammatory bowel disease.